Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2009-10-19 Board/Management Inform…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Board/Management Information 2009
Board/Management Information Classification · 99% confidence The document is a short press release from Biotage AB dated October 19, 2009. The primary content announces the formation of a Nomination Committee ('Valberedning') whose task is to prepare proposals for the election of the Board of Directors, chairman, and remuneration issues ahead of the Annual General Meeting (AGM) in 2010. This content directly relates to the preparation and governance surrounding the AGM, specifically concerning board nominations and remuneration, which falls under Governance Information (CGR) or potentially AGM-related material. Since it is an announcement about the composition of the body responsible for preparing AGM elections and remuneration, it is most closely aligned with Governance Information (CGR) or potentially Remuneration Information (DEF 14A) or AGM Information (AGM-R). Given the focus on the composition of the nomination committee preparing for board elections and remuneration ahead of the AGM, CGR (Governance Information) is a strong fit, as is AGM-R. However, DEF 14A is specifically for compensation reports. Since this is about the *process* of nominating directors and setting remuneration for the upcoming AGM, CGR is the most appropriate fit for general governance structure preparation, although AGM-R is also plausible. Given the context of preparing for the AGM elections and remuneration, I will classify it as AGM-R as it is directly preparatory material for the AGM process.
2009-10-19 Swedish
Board/Management Information 2009
Board/Management Information Classification · 99% confidence The document is a press release from Biotage AB dated October 19, 2009, announcing the formation of a Nomination Committee. This committee is tasked with preparing proposals for the election of the Board of Directors and determining fees ahead of the Annual General Meeting (AGM) 2010. While the content relates to the AGM, the primary subject is the composition and mandate of the Nomination Committee, which falls under governance and board structure information. This aligns best with the 'Governance Information' (CGR) category, which covers internal rules and board structure. It is not a formal AGM presentation (AGM-R), a proxy statement (PSI), or a declaration of voting results (DVA). Given the focus on the committee responsible for board nominations, CGR is the most appropriate fit.
2009-10-19 English
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Biotage covering the period January-June 2009. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, risks, and outlook. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). H1 2009
2009-08-14 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' for the period January - June 2009. It contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary on business performance. It is not a mere announcement or certification, but the full interim financial report itself, fitting the definition of an Interim / Quarterly Report (IR). H1 2009
2009-08-14 English
Transaction in Own Shares 2009
Transaction in Own Shares Classification · 99% confidence The document is a press release from Biotage AB dated June 22, 2009, titled "Biotage AB inleder återköp av egna aktier" (Biotage AB initiates repurchase of own shares). The text explicitly states that the Board has decided to initiate a share repurchase program, referencing the authorization granted at the Annual General Meeting (AGM). This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2009-06-22 Swedish
Transaction in Own Shares 2009
Transaction in Own Shares Classification · 99% confidence The document is a press release from Biotage AB dated June 22, 2009, announcing that the board has resolved to start a 'share buy-back program'. The text explicitly mentions the authorization came from the Annual General Meeting and the purpose is related to the company's capital structure. This directly relates to the company acquiring or selling its own shares. Based on the definitions, the category 'Transaction in Own Shares (Code: POS)' is the most appropriate fit, as it covers share repurchase programs.
2009-06-22 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.